Arienti KL - Search Results

1

Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles.

Arienti KL, Brunmark A, Axe FU, McClure K, Lee A, Blevitt J, Neff DK, Huang L, Crawford S, Pandit CR, Karlsson L, Breitenbucher JG. Arienti KL, et al. J Med Chem. 2005 Mar 24;48(6):1873-85. doi: 10.1021/jm0495935. J Med Chem. 2005. PMID: 15771432

2

Novel non-benzimidazole chk2 kinase inhibitors.

McClure KJ, Huang L, Arienti KL, Axe FU, Brunmark A, Blevitt J, Breitenbucher JG. McClure KJ, et al. Among authors: arienti kl. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1924-8. doi: 10.1016/j.bmcl.2005.12.096. Epub 2006 Jan 25. Bioorg Med Chem Lett. 2006. PMID: 16442290

3

Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.

Lee-Dutra A, Arienti KL, Buzard DJ, Hack MD, Khatuya H, Desai PJ, Nguyen S, Thurmond RL, Karlsson L, Edwards JP, Breitenbucher JG. Lee-Dutra A, et al. Among authors: arienti kl. Bioorg Med Chem Lett. 2006 Dec 1;16(23):6043-8. doi: 10.1016/j.bmcl.2006.08.117. Epub 2006 Sep 20. Bioorg Med Chem Lett. 2006. PMID: 16990005

4

Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1.

Lee-Dutra A, Wiener DK, Arienti KL, Liu J, Mani N, Ameriks MK, Axe FU, Gebauer D, Desai PJ, Nguyen S, Randal M, Thurmond RL, Sun S, Karlsson L, Edwards JP, Jones TK, Grice CA. Lee-Dutra A, et al. Among authors: arienti kl. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2370-4. doi: 10.1016/j.bmcl.2010.01.108. Epub 2010 Jan 28. Bioorg Med Chem Lett. 2010. PMID: 20153648

5

Scope and limitations of solid-supported liquid-liquid extraction for the high-throughput purification of compound libraries.

Breitenbucher JG, Arienti KL, McClure KJ. Breitenbucher JG, et al. Among authors: arienti kl. J Comb Chem. 2001 Nov-Dec;3(6):528-33. doi: 10.1021/cc010039f. J Comb Chem. 2001. PMID: 11703147

6

Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.

Higuchi RI, Arienti KL, López FJ, Mani NS, Mais DE, Caferro TR, Long YO, Jones TK, Edwards JP, Zhi L, Schrader WT, Negro-Vilar A, Marschke KB. Higuchi RI, et al. Among authors: arienti kl. J Med Chem. 2007 May 17;50(10):2486-96. doi: 10.1021/jm061329j. Epub 2007 Apr 17. J Med Chem. 2007. PMID: 17439112

7

Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectors.

Choe JY, Nelson SW, Arienti KL, Axe FU, Collins TL, Jones TK, Kimmich RD, Newman MJ, Norvell K, Ripka WC, Romano SJ, Short KM, Slee DH, Fromm HJ, Honzatko RB. Choe JY, et al. Among authors: arienti kl. J Biol Chem. 2003 Dec 19;278(51):51176-83. doi: 10.1074/jbc.M308396200. Epub 2003 Oct 6. J Biol Chem. 2003. PMID: 14530289 Free article.

8

4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonists.

Higuchi RI, Edwards JP, Caferro TR, Ringgenberg JD, Kong JW, Hamann LG, Arienti KL, Marschke KB, Davis RL, Farmer LJ, Jones TK. Higuchi RI, et al. Among authors: arienti kl. Bioorg Med Chem Lett. 1999 May 3;9(9):1335-40. doi: 10.1016/s0960-894x(99)00186-9. Bioorg Med Chem Lett. 1999. PMID: 10340624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page